Omgene Life Science
has expertise in development of Complex steroids, anti-tubercular drugs, deuteriated APIs, Sugar & cyclodextrin derivatives, Anti-viral and anti-diabetic Actives.
Brexanolone is a naturally occurring neurosteroid which
is made in the body from the hormone progesterone.As
a medication, brexanolone is also referred to as allopregnanolone.
Nitisinone, is a medication used
to slow the effects of hereditary
tyrosinemia type 1 (HT-1)
Sugammadex, sold under the brand name Bridion, is a
medication for the reversal of neuromuscular
blockade induced by rocuronium and vecuroniumin general anaesthesia.
It is the first selective relaxant binding agent (SRBA).
Saroglitazar is a drug for
the treatment of type 2 diabetes mellitus and dyslipidemia.
It is approved for use in India by the Drug Controller General of India.Saroglitazar
is indicated for the treatment of diabetic dyslipidemia
and hypertriglyceridemia with
type 2 diabetes mellitus not controlled by statin therapy.
Brivaracetam,
is a chemical analog of levetiracetam , is
a racetam derivative with anticonvulsant (antiepileptic)
properties.
Bedaquiline: a quinoline-based antimycobacterial drug used (as its
fumarate salt) for the treatment of pulmonary multi-drug resistant tuberculosis by
inhibition of ATP synthase, an enzyme essential for the replication of the mycobacteria. It
has a role as an antitubercular agent and an ATP synthase inhibitor. It is a member of
quinolines, a member of naphthalenes, an organobromine compound, an aromatic ether, a
tertiary alcohol and a tertiary amino compound. It is a conjugate base of a bedaquiline(2+).
Mebendazole: a carbamate ester that is methyl
1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5. It has a role as
an antinematodal drug, a tubulin modulator and a microtubule-destabilising agent. It is a
member of benzimidazoles, a carbamate ester and an aromatic ketone. It derives from a
hydride of a 1H-benzimidazole.
Isavuconazonium sulfate: an azaheterocycle sulfate salt that is a
prodrug for isavuconazole, an antifungal agent used for the treatment of invasive
aspergillosis and invasive mucormycosis. It has a role as a prodrug, an ergosterol
biosynthesis inhibitor, an EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor and an
orphan drug. It is an azaheterocycle sulfate salt, a triazole antifungal drug and a conazole
antifungal drug. It contains an isavuconazonium.
Rufinamide: a triazole derivative and an anticonvulsant medication to
treat seizure disorders like Lennox-Gastuat syndrome, a form of childhood epilepsy. Clinical
trials suggest its efficacy in the treatment of partial seizures.
Selexipag: a member of the class of pyrazines that is
N-(methanesulfonyl)-2-{4-[(propan-2-yl)(pyrazin-2-yl)amino]butoxy}acetamide carrying two
additional phenyl substituents at positions 5 and 6 on the pyrazine ring. An orphan drug
used for the treatment of pulmonary arterial hypertension. It is a prodrug for ACT-333679
(the free carboxylic acid). It has a role as an orphan drug, a prostacyclin receptor
agonist, a platelet aggregation inhibitor, a vasodilator agent and a prodrug. It is a
monocarboxylic acid amide, an ether, a member of pyrazines, an aromatic amine, a tertiary
amino compound and a N-sulfonylcarboxamide. It is functionally related to an ACT-333679.
Apremilast: a member of the class of isoindoles that is
isoindole-1,3-dione substituted at position 4 by an acetamido group and at position 1 by a
1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl group. Used for treatment of psoriatic
arthritis. It has a role as a phosphodiesterase IV inhibitor and a non-steroidal
anti-inflammatory drug. It is an aromatic ether, a N-acetylarylamine, a sulfone and a member
of phthalimides.
Molnupiravir: a nucleoside analogue that is N(4)-hydroxycytidine in
which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug
of the active antiviral ribonucleoside analog N(4)-hydroxycytidine (EIDD-1931), has activity
against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic
influenza viruses. It is currently in phase III trials for the treatment of patients with
COVID-19. It has a role as a prodrug, an anticoronaviral agent and an antiviral drug. It is
a nucleoside analogue, an isopropyl ester and a ketoxime. It is functionally related to a
N(4)-hydroxycytidine.
Brexanolone
Apremilast
Bedaquiline
Brivaracetam
Deutetrabenazine
Isavuconazonium Sulfate
Molnupiravir
Nitisinone
Rufinamide
Saroglitazar
Selexipag
Sugammadex
Established in 2011, as a private limited company registered under Companies Act, 1956, we
are quickly growing towards creating a vast impact on the healthcare industry.